These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 25089373)

  • 21. Modified intra-cerebral challenge assay for acellular pertussis vaccines: comparisons among whole cell and acellular vaccines.
    Gaines-Das R; Horiuchi Y; Zhang SM; Newland P; Kim Y; Corbel M; Xing D
    Vaccine; 2009 Nov; 27(49):6824-32. PubMed ID: 19765397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of a single dose of acellular pertussis vaccine to prevent pertussis in children primed with pertussis whole cell vaccine.
    De Serres G; Shadmani R; Boulianne N; Duval B; Rochette L; Douville Fradet M; Halperin SA
    Vaccine; 2001 Apr; 19(20-22):3004-8. PubMed ID: 11282212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of two pertussis vaccines in preterm Danish children.
    Hviid A
    Vaccine; 2009 May; 27(23):3035-8. PubMed ID: 19428916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acellular vaccines for preventing whooping cough in children.
    Zhang L; Prietsch SO; Axelsson I; Halperin SA
    Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD001478. PubMed ID: 25228233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pertussis: Where did we go wrong and what can we do about it?
    Locht C
    J Infect; 2016 Jul; 72 Suppl():S34-40. PubMed ID: 27161992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of injection site on reactogenicity and immunogenicity of acellular and whole-cell pertussis component diphtheria-tetanus-pertussis vaccines in infants.
    Tapiainen T; Cherry JD; Heininger U
    Vaccine; 2005 Oct; 23(43):5106-12. PubMed ID: 16023771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changing pertussis epidemiology: everything old is new again.
    Clark TA
    J Infect Dis; 2014 Apr; 209(7):978-81. PubMed ID: 24626532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acellular pertussis vaccines and pertussis resurgence: revise or replace?
    Ausiello CM; Cassone A
    mBio; 2014 Jun; 5(3):e01339-14. PubMed ID: 24917600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune responses to pertussis vaccines and disease.
    Edwards KM; Berbers GA
    J Infect Dis; 2014 Apr; 209 Suppl 1():S10-5. PubMed ID: 24158958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pertussis: acellular, whole-cell, new vaccines, what to choose?
    Locht C
    Expert Rev Vaccines; 2016 Jun; 15(6):671-3. PubMed ID: 26938372
    [No Abstract]   [Full Text] [Related]  

  • 31. Pertussis vaccines and the challenge of inducing durable immunity.
    Warfel JM; Edwards KM
    Curr Opin Immunol; 2015 Aug; 35():48-54. PubMed ID: 26091979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What Is Wrong with Pertussis Vaccine Immunity? Why Immunological Memory to Pertussis Is Failing.
    Diavatopoulos DA; Edwards KM
    Cold Spring Harb Perspect Biol; 2017 Dec; 9(12):. PubMed ID: 28289059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and Validation of a
    da Silva Antunes R; Quiambao LG; Sutherland A; Soldevila F; Dhanda SK; Armstrong SK; Brickman TJ; Merkel T; Peters B; Sette A
    J Immunol Res; 2020; 2020():8202067. PubMed ID: 32322598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of 13 acellular pertussis vaccines: overview and serologic response.
    Edwards KM; Meade BD; Decker MD; Reed GF; Rennels MB; Steinhoff MC; Anderson EL; Englund JA; Pichichero ME; Deloria MA
    Pediatrics; 1995 Sep; 96(3 Pt 2):548-57. PubMed ID: 7659475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine.
    Gustafsson L; Hallander HO; Olin P; Reizenstein E; Storsaeter J
    N Engl J Med; 1996 Feb; 334(6):349-55. PubMed ID: 8538705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recommendations to control pertussis prioritized relative to economies: A Global Pertussis Initiative update.
    Forsyth KD; Tan T; von König CW; Heininger U; Chitkara AJ; Plotkin S
    Vaccine; 2018 Nov; 36(48):7270-7275. PubMed ID: 30337176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of pertussis: An unresolved problem.
    Esposito S; Principi N
    Hum Vaccin Immunother; 2018; 14(10):2452-2459. PubMed ID: 29856680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective Effect of Contemporary Pertussis Vaccines: A Systematic Review and Meta-analysis.
    Fulton TR; Phadke VK; Orenstein WA; Hinman AR; Johnson WD; Omer SB
    Clin Infect Dis; 2016 May; 62(9):1100-1110. PubMed ID: 26908803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outer membrane vesicles derived from Bordetella parapertussis as an acellular vaccine against Bordetella parapertussis and Bordetella pertussis infection.
    Bottero D; Gaillard ME; Errea A; Moreno G; Zurita E; Pianciola L; Rumbo M; Hozbor D
    Vaccine; 2013 Oct; 31(45):5262-8. PubMed ID: 24012570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of the immune response induced by pertussis OMVs-based vaccine.
    Bottero D; Gaillard ME; Zurita E; Moreno G; Martinez DS; Bartel E; Bravo S; Carriquiriborde F; Errea A; Castuma C; Rumbo M; Hozbor D
    Vaccine; 2016 Jun; 34(28):3303-9. PubMed ID: 27151884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.